Quick Comparison

HMGOxytocin
Half-LifeFSH component: 30 hours | LH component: 24 hours3-5 minutes (IV); intranasal effects persist longer due to sustained CNS absorption
Typical DosageFertility (women): 75-150 IU intramuscular once daily, physician-directed with ultrasound monitoring. PCT/bodybuilding: 75-150 IU intramuscular every other day for 1-2 weeks, often alongside HCG.Intranasal (behavioral): 20-40 IU per dose as needed. Labor induction (Pitocin): 0.5-2 mU/min IV infusion, titrated by physician. Compounded sublingual and nasal sprays available for off-label use.
AdministrationIntramuscular or subcutaneous injectionIntranasal spray, sublingual, or intravenous (medical)
Research Papers30 papers30 papers
Categories

Mechanism of Action

HMG

Human Menopausal Gonadotropin is a purified urinary extract containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity, sourced from the urine of postmenopausal women. After menopause, the loss of ovarian negative feedback (estradiol and inhibin) results in dramatically elevated pituitary gonadotropin secretion — FSH and LH levels rise 10-20 fold, providing a natural source of these hormones for pharmaceutical extraction.

The FSH component binds to FSH receptors (FSHR) on Sertoli cells in males and granulosa cells in females. FSHR is a Gs-coupled GPCR that activates cAMP/PKA signaling, driving the expression of genes essential for gametogenesis. In males, FSH-stimulated Sertoli cells produce androgen-binding protein (which concentrates testosterone locally), inhibin B (which provides negative feedback to the pituitary), and multiple growth factors that support spermatogonial proliferation and differentiation through the stages of spermatogenesis. In females, FSH drives follicular development — stimulating granulosa cell proliferation, estradiol synthesis via aromatase induction, and the growth of ovarian follicles from the pre-antral to the pre-ovulatory stage.

The LH component acts on Leydig cells in males (stimulating testosterone production via the LHCGR/cAMP/StAR steroidogenic pathway) and on theca cells in females (stimulating androgen precursor production that granulosa cells convert to estradiol). In females undergoing fertility treatment, the LH component is also critical for final oocyte maturation and ovulation triggering. The combination of both FSH and LH activity in HMG provides more complete gonadal stimulation than either gonadotropin alone — FSH drives the cellular proliferation and maturation processes while LH provides the steroidogenic and final maturation signals. This dual activity is why HMG is sometimes preferred over purified FSH preparations in certain fertility protocols, particularly in hypogonadotropic patients who lack endogenous LH.

Oxytocin

Oxytocin is a nonapeptide (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2) synthesized in magnocellular neurosecretory neurons of the paraventricular and supraoptic nuclei of the hypothalamus. These neurons project to the posterior pituitary, where oxytocin is released into systemic circulation, and also to various brain regions where it acts as a neurotransmitter/neuromodulator.

Oxytocin binds to the oxytocin receptor (OXTR), a Gq/11-coupled GPCR expressed in both the brain and peripheral tissues. Central OXTR activation in the amygdala attenuates fear and anxiety responses by dampening amygdala reactivity to threatening stimuli. In the nucleus accumbens and ventral tegmental area, oxytocin modulates dopaminergic reward circuitry, strengthening the association between social interaction and reward — the neurobiological basis of social bonding, trust, and attachment. In the hippocampus, oxytocin enhances social memory formation, allowing individuals to recognize and respond differentially to familiar versus unfamiliar social partners.

Peripherally, oxytocin's most well-characterized effect is on uterine smooth muscle — OXTR activation triggers phospholipase C-mediated calcium release, causing rhythmic myometrial contractions essential for labor and delivery. Synthetic oxytocin (Pitocin) exploits this mechanism for labor induction. In mammary tissue, oxytocin causes contraction of myoepithelial cells surrounding alveoli, ejecting milk into the ductal system (the milk let-down reflex). This reflex is triggered by infant suckling, which stimulates afferent nerves that signal the hypothalamus to release oxytocin in a positive feedback loop.

The behavioral effects of intranasal oxytocin are dose-dependent and context-dependent — while often characterized as a 'bonding' or 'trust' hormone, oxytocin actually amplifies the salience of social cues, which can increase in-group favoritism and out-group suspicion. Its effects on social cognition are nuanced and modulated by individual differences in OXTR expression, attachment style, and social context.

Risks & Safety

HMG

Common

pain and bruising at the injection site, headache, bloating, tender breasts.

Serious

in women, can cause dangerous overstimulation of the ovaries (potentially life-threatening), and increases the chance of twins or higher-order multiples; in men, can cause breast tissue growth.

Rare

blood clots, twisted ovary, severe allergic reaction. Requires close monitoring with blood tests and ultrasounds during fertility treatment.

Oxytocin

Common

headache, nasal irritation, mild dizziness, uterus contracting too strongly when used IV during labor.

Serious

at high IV doses, can cause dangerous fluid retention and low sodium; excessive stimulation can rarely cause uterine rupture.

Rare

severe allergic reaction, irregular heartbeat.

Full Profiles